Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
AIM ImmunoTech Inc (AIM)
NYSE MKT:AIM
AIM ImmunoTech (AIM) Stock Price & Analysis
815 Followers
AIM Stock Chart & Stats
Day’s Range$0.39 - $0.44
52-Week Range― - ―
Previous Close$0.43
Volume107.97K
Average Volume (3M)N/A
Market Cap
$19.05M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 16, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$2.00Price Target Upside418.54% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
AIM ImmunoTech News
Ownership Overview
7.99% Insiders
4.81% Mutual Funds
4.03% Other Institutional Investors
83.17% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
AIM FAQ
What was AIM ImmunoTech Inc’s price range in the past 12 months?
Currently, no data Available
What is AIM ImmunoTech Inc’s market cap?
Currently, no data Available
When is AIM ImmunoTech Inc’s upcoming earnings report date?
AIM ImmunoTech Inc’s upcoming earnings report date is May 16, 2024 which is in 21 days.
How were AIM ImmunoTech Inc’s earnings last quarter?
AIM ImmunoTech Inc released its earnings results on Apr 02, 2024. The company reported -$0.26 earnings per share for the quarter, missing the consensus estimate of -$0.12 by -$0.14.
Is AIM ImmunoTech Inc overvalued?
According to Wall Street analysts AIM ImmunoTech Inc’s price is currently Undervalued.
Does AIM ImmunoTech Inc pay dividends?
AIM ImmunoTech Inc does not currently pay dividends.
What is AIM ImmunoTech Inc’s EPS estimate?
AIM ImmunoTech Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AIM ImmunoTech Inc have?
Currently, no data Available
What happened to AIM ImmunoTech Inc’s price movement after its last earnings report?
AIM ImmunoTech Inc reported an EPS of -$0.26 in its last earnings report, missing expectations of -$0.12. Following the earnings report the stock price went down -8.163%.
Which hedge fund is a major shareholder of AIM ImmunoTech Inc?
Currently, no hedge funds are holding shares in AIM
---
AIM ImmunoTech Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.00 (418.54% Upside)
$2.00 (418.54% Upside)
Insider Transactions
Bought Shares
Worth $82.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 9.2%
Last 30 Days ▼ 9.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.37%
12-Months-Change
Fundamentals
Return on Equity
-118.94%
Trailing 12-Months
Asset Growth
-72.23%
Trailing 12-Months
Company Description
AIM ImmunoTech Inc
AIM ImmunoTech, Inc. operates as a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Orlando, FL.
---
AIM Earnings Call
Q4 2024
0:00 / 0:00
---
AIM Stock 12 Months Forecast
Average Price Target
$2.00
▲(418.54% Upside)
Technical Analysis
Best Analysts Covering AIM
1 Year
1 Year Success Rate
2/11 ratings generated profit
1 Year Average Return
-17.40%
reiterated a buy rating 24 days ago
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 18.18% of your transactions generating a profit, with an average return of -17.40% per trade.
---